#USA #St. Paul #Robotic Surgery #iotaMotion #iotaSOFT

IotaMotion Strengthens Its Position in Cochlear Implant Surgery

IotaMotion, Inc., a pioneer in robotic-assisted systems for cochlear implant surgery, proudly announces the issuance of U.S. Patent No. 12,558,123. This newly secured patent amplifies the company’s already robust intellectual property portfolio in robotic-assisted cochlear implantation technology. The iotaSOFT® system represents a transformative approach, advancing the standard of care in hearing restoration through precise surgical techniques.

The iotaSOFT® System

The iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System is distinguished as the first and only FDA-cleared robotic system for cochlear implant procedures. Created to facilitate a slow, consistent, and controlled insertion of electrodes, it aims to protect the fragile structures within the cochlea. This innovation provides an essential solution, addressing the significant unmet need for cochlear implants, given that fewer than 5% of the more than 60 million individuals worldwide who could benefit from them currently receive these life-changing devices.

A Game Changer for Hearing Loss Treatment

According to data from the World Health Organization, there are over 430 million people globally who suffer from moderate to severe hearing loss. Despite the promising capabilities of cochlear implants, a staggering statistic reveals that eligible patients represent only a fraction of those who receive them. The mechanical precision offered by the iotaSOFT systems marks a critical advancement in surgical technology, set to enhance treatment outcomes and accessibility.

CEO Insight and Future Directions

Mike Lobinsky, CEO of iotaMotion, emphasizes the importance of this patent acquisition: "This new patent augments our strong intellectual property portfolio, which broadly covers systems and methods related to robotic positioning and control in cochlear implant surgery. Protecting the technologies that standardize and control electrode insertion is central to sustaining our leadership in this field."

The iotaSOFT system not only enhances surgical accuracy but sets a new standard for robotic technologies in medical procedures, reinforcing iotaMotion’s commitment to lead innovation in this sector. As the company seeks to expand its impact, the focus remains on ensuring that more individuals have access to cochlear implants, thereby transforming lives with improved hearing capabilities.

The Path Forward

As robotic-assisted technology continues to find its place within clinical settings, it will play a crucial role in reshaping cochlear implant surgeries. iotaMotion’s ongoing efforts to enhance its patent portfolio signify a strategic approach to safeguard its innovative technologies. Not only does the company aim to improve surgical outcomes, but it also strives to inspire further adoption of such technologies in hospitals and clinics worldwide.

Conclusion

iotaMotion stands at the forefront of revolutionizing cochlear implantation practices with its patented iotaSOFT® system. Its efforts not only address current inefficiencies within the healthcare landscape but also advocate for greater accessibility in hearing restoration. By strengthening its intellectual property rights and continuously innovating, iotaMotion is poised to lead the future of robotic-assisted surgical procedures, ensuring that advancements in technology translate into tangible benefits for those affected by hearing loss.